ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
64,488.47
0.93%
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs Yen
153.055
0.00%
Brent Oil
82.765
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Benitec Biopharma Limited (BNTC)

  7. Benitec Biopharma Limited (BNTC) ニュース

BNTC

Benitec Biopharma (BNTC)

Benitec Biopharma Limited
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:BNTC
日付受信時刻ニュースソース見出しコード企業名
2024/03/0906 : 17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
2024/03/0906 : 13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNTCBenitec Biopharma Limited
2024/03/0906 : 12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNTCBenitec Biopharma Limited
2024/03/0614 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BNTCBenitec Biopharma Limited
2024/02/2623 : 06Edgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:BNTCBenitec Biopharma Limited
2024/02/2406 : 09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BNTCBenitec Biopharma Limited
2024/02/1322 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
2024/02/1322 : 01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BNTCBenitec Biopharma Limited
2023/12/0806 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
2023/11/3021 : 31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
2023/11/1722 : 00GlobeNewswire Inc.Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:BNTCBenitec Biopharma Limited
2023/11/1322 : 03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
2023/11/1322 : 00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BNTCBenitec Biopharma Limited
2023/11/1322 : 00GlobeNewswire Inc.Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational UpdateNASDAQ:BNTCBenitec Biopharma Limited
2023/10/2105 : 31Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BNTCBenitec Biopharma Limited
2023/10/2019 : 04Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BNTCBenitec Biopharma Limited
2023/10/1706 : 29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
2023/09/2906 : 19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
2023/09/2121 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
2023/09/2121 : 00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BNTCBenitec Biopharma Limited
2023/09/2121 : 00GlobeNewswire Inc.Benitec Biopharma Releases Full Year 2023 Financial Results and Provides Operational UpdateNASDAQ:BNTCBenitec Biopharma Limited
2023/09/1906 : 26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
2023/08/1506 : 13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNTCBenitec Biopharma Limited
2023/08/1205 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
2023/08/1202 : 00GlobeNewswire Inc.Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public OfferingNASDAQ:BNTCBenitec Biopharma Limited
2023/08/1105 : 42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
2023/08/1105 : 06Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:BNTCBenitec Biopharma Limited
2023/08/1105 : 06Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:BNTCBenitec Biopharma Limited
2023/08/0913 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BNTCBenitec Biopharma Limited
2023/08/0911 : 30GlobeNewswire Inc.Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public OfferingNASDAQ:BNTCBenitec Biopharma Limited
 Showing the most relevant articles for your search:NASDAQ:BNTC

最近閲覧した銘柄

NYSE
VZ
Verizon Communications
AMEX
XLE
Energy Select Sector SPDR
NYSE
CVX
Chevron
NYSE
MCD
McDonalds
NYSE
NKE
Nike
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
NVDA
NVIDIA
NASDAQ
QQQ
Invesco QQQ Trust Series 1
CCOM
US30
US 30
FX
USDGBP
US Dollar vs Sterling
NASDAQ
AAPL
Apple
USOTC
BASFY
BASF (QX)
NASDAQ
TSLA
Tesla
AMEX
XLV
Health Care Select Sector
CCOM
US500
US 500
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有